Vanda Pharmaceuticals Inc. v. Lupin Limited
1:15-cv-01073
Overview
Parties
Defendant
Lupin Pharmaceuticals Inc. Operating Company
Represented By
3 Attorneys ListedSeitz, Van Ogtrop & Green, P.A.
Seitz, Van Ogtrop & Green, P.A., 222 Delaware Avenue, Suite 1500
Landis Rath & Cobb LLP
919 Market Street, Suite 1800, P.O. Box 2087
Landis Rath & Cobb LLP
919 Market Street, Suite 1800, P.O. Box 2087
Lupin Limited NPE (University / Research)
Represented By
6 Attorneys ListedSeitz, Van Ogtrop & Green, P.A.
Seitz, Van Ogtrop & Green, P.A., 222 Delaware Avenue, Suite 1500
Landis Rath & Cobb LLP
919 Market Street, Suite 1800, P.O. Box 2087
Landis Rath & Cobb LLP
919 Market Street, Suite 1800, P.O. Box 2087
Plaintiff
Vanda Pharmaceuticals Inc. Operating Company
Represented By
9 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
McDermott Will & Emery LLP
4th floor, 1007 North Orange Street, 4th Floor
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 8,586,610 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 61,479,804 P | US Continuation / Sibling | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 2006039663 A2 | PCT World Application | View Official Patent → |
| 🇺🇸 United States | US 2010006309 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2014004589 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 9 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8586610
Methods for the administration of iloperidone
|
Filed: 2005-09-30
Issued: 2013-11-19
|
Active (1.0 yrs remaining)
+763d PTA
Expires: 2027-11-02
|
|
|
US9138432
Methods for the administration of iloperidone
|
Filed: 2014-01-08
Issued: 2015-09-22
|
Active (7.1 yrs remaining)
Expires: 2034-01-08
|
|
|
US8652776
Prediction of QT prolongation based on SNP genotype
|
Filed: 2008-09-10
Issued: 2014-02-18
|
Active (3.8 yrs remaining)
+720d PTA
Expires: 2030-08-31
|
|
|
US8999638
Method of treatment based on polymorphisms of the KCNQ1 gene
|
Filed: 2010-04-05
Issued: 2015-04-07
|
Active (3.9 yrs remaining)
+206d PTA
Expires: 2030-10-28
|
|
|
US9072742
Method of predicting a predisposition to QT prolongation
|
Filed: 2010-04-05
Issued: 2015-07-07
|
Active (4.2 yrs remaining)
+286d PTA
Expires: 2031-01-16
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
High PTA (+763 days) / Cellect Scrutiny — Over 763 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
17
Dispositive
6
Granted
0
Denied
0
Pending / Review
17
Motions by Category
Key Dispositive Motions & Rulings